this assay system was used for a preliminary clinical study , which revealed elevated mad-2 levels in sera from pregnant women and individuals with various carcinomas , compared to levels in sera obtained from normal individuals , patients with nonmalignant diseases , or fetal cord samples .
C0027361
individuals
C0015965
fetal